Colorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.
With communities across the nation experiencing a wave of COVID-19 infections, clinicians need effective tools that will enable them to aggressively and accurately treat each patient based on their specific disease presentation, health history, and medical risks.
In research recently published online in Medical Image Analysis, a team of engineers demonstrated how a new algorithm they developed was able to successfully predict whether or not a COVID-19 patient would need ICU intervention. This artificial intelligence-based approach could be a valuable tool in determining a proper course of treatment for individual patients.
The research team, led by Pingkun Yan, an assistant professor of biomedical engineering at Rensselaer Polytechnic Institute, developed this method by combining chest computed tomography (CT) images that assess the severity of a patient’s lung infection with non-imaging data, such as demographic information, vital signs, and laboratory blood test results. By combining these data points, the algorithm is able to predict patient outcomes, specifically whether or not a patient will need ICU intervention.
The algorithm was tested on datasets collected from a total of 295 patients from three different hospitals — one in the United States, one in Iran, and one in Italy. Researchers were able to compare the algorithm’s predictions to what kind of treatment a patient actually ended up needing.
“As a practitioner of AI, I do believe in its power,” said Yan, who is a member of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer. “It really enables us to analyze a large quantity of data and also extract the features that may not be that obvious to the human eye.”
This development is the result of research supported by a recent National Institutes of Health grant, which was awarded to provide solutions during this worldwide pandemic. As the team continues its work, Yan said, researchers will integrate their new algorithm with another that Yan had previously developed to assess a patient’s risk of cardiovascular disease using chest CT scans.
“We know that a key factor in COVID mortality is whether a patient has underlying conditions and heart disease is a significant comorbidity,” Yan said. “How much this contributes to their disease progress is, right now, fairly subjective. So, we have to have a quantification of their heart condition and then determine how we factor that into this prediction.”
“This critical work, led by Professor Yan, offers an actionable solution for clinicians who are in the middle of a worldwide pandemic,” said Deepak Vashishth, the director of CBIS. “This project highlights the capabilities of Rensselaer expertise in bioimaging combined with important partnerships with medical institutions.”
Yan is joined at Rensselaer by Ge Wang, an endowed chair professor of biomedical engineering and member of CBIS, as well as graduate students Hanqing Chao, Xi Fang, and Jiajin Zhang. The Rensselaer team is working in collaboration with Massachusetts General Hospital. When this work is complete, Yan said, the team hopes to translate its algorithm into a method that doctors at Massachusetts General can use to assess their patients.
“We actually are seeing that the impact could go well beyond COVID diseases. For example, patients with other lung diseases,” Yan said. “Assessing their heart disease condition, together with their lung condition, could better predict their mortality risk so that we can help them to manage their condition.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- University forces professors back into the classroom despite covid-19, but students get to chooseon January 23, 2021 at 10:00 am
Professors and teaching assistants at the University of Florida balk at what they see as a double standard. Students can report absent teachers using a "snitch app." ...
- Full-Dose Blood Thinners Reduced Need For Respiratory Support And Improved Outcomes In Non-ICU Covid-19 Patients, Study Findson January 23, 2021 at 9:48 am
Based on a new NIH report, full-dose anticoagulation was found to be more beneficial compared to lower prophylactic doses in reducing the need for critical lifesaving measures such as mechanical ...
- Digital Health Company eMed™ Launches At-Home COVID-19 Rapid Testingon January 23, 2021 at 9:16 am
PRNewswire/ -- eMed™, a digital health company democratizing healthcare through digital point-of-care solutions, announced it will begin to administer ...
- Black Patients Hospitalized With COVID-19 Show High Incidence of Comorbidities, Mortalityon January 23, 2021 at 8:28 am
Black patients hospitalized with coronavirus disease 2019 from an urban academic medical center in New York City exhibited high rates of comorbidities and in-hospital mortality, with chronic ...
- Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patientson January 23, 2021 at 7:51 am
In large clinical trial conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Artificial intelligence algorithm
- UVA clinicians using artificial intelligence to track risk of ICU patientson January 22, 2021 at 1:33 pm
A new artificial intelligence program created by UVA Health researchers can now monitor high-risk coronavirus patients, as well as others in intensive care, and alert nurses and doctors if ...
- Artificial Intelligence Is a Work in Progress, Official Sayson January 22, 2021 at 12:26 pm
Expectations are high that artificial intelligence will be a game changer for the military — and it is, in fact, one of the Defense Department's top priorities.
- What Nonprofits Stand To Gain From Artificial Intelligenceon January 22, 2021 at 4:00 am
Nonprofits have the opportunity to develop AI powerful algorithms to raise more funds, improve the efficiency of their resources and learn more about their members' needs.
- FDA Issues Artificial Intelligence/Machine Learning Action Planon January 21, 2021 at 11:19 am
On January 12, 2021, the US Food and Drug Administration (FDA) released its Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. The Action Plan ...
- Aiforia partners with Pathan to bring artificial intelligence assisted diagnostics to the pathology labon January 21, 2021 at 7:21 am
Pathan, one of the largest pathology laboratories in the Netherlands, has started a collaboration with Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical ...